Encompass Health Corporation $EHC Stake Cut by Select Asset Management & Trust

Select Asset Management & Trust cut its position in shares of Encompass Health Corporation (NYSE:EHC) by 40.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,387 shares of the company’s stock after selling 5,000 shares during the quarter. Select Asset Management & Trust’s holdings in Encompass Health were worth $784,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. EP Wealth Advisors LLC lifted its stake in Encompass Health by 2.4% during the second quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock worth $453,000 after purchasing an additional 88 shares during the last quarter. Allworth Financial LP lifted its stake in Encompass Health by 14.7% during the third quarter. Allworth Financial LP now owns 701 shares of the company’s stock worth $89,000 after purchasing an additional 90 shares during the last quarter. Westside Investment Management Inc. increased its position in Encompass Health by 56.7% in the third quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock worth $35,000 after buying an additional 101 shares during the period. Leuthold Group LLC increased its position in Encompass Health by 0.3% in the fourth quarter. Leuthold Group LLC now owns 31,168 shares of the company’s stock worth $3,308,000 after buying an additional 104 shares during the period. Finally, Covestor Ltd increased its position in Encompass Health by 24.4% in the fourth quarter. Covestor Ltd now owns 540 shares of the company’s stock worth $57,000 after buying an additional 106 shares during the period. 97.25% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on EHC shares. TD Cowen started coverage on Encompass Health in a research report on Thursday. They issued a “buy” rating and a $125.00 target price on the stock. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Barclays dropped their target price on Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 5th. Finally, Leerink Partners set a $152.00 target price on Encompass Health in a research report on Friday, May 22nd. Two investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, Encompass Health presently has a consensus rating of “Buy” and a consensus target price of $142.75.

Insider Transactions at Encompass Health

In related news, EVP Patrick William Tuer sold 682 shares of Encompass Health stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $104.56, for a total transaction of $71,309.92. Following the transaction, the executive vice president directly owned 24,755 shares of the company’s stock, valued at $2,588,382.80. The trade was a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Treasurer Edmund Fay sold 11,937 shares of Encompass Health stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $107.00, for a total value of $1,277,259.00. Following the transaction, the treasurer directly owned 89,325 shares in the company, valued at approximately $9,557,775. The trade was a 11.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.80% of the stock is owned by insiders.

Encompass Health Price Performance

Shares of EHC opened at $102.60 on Tuesday. The firm has a market capitalization of $10.18 billion, a price-to-earnings ratio of 17.13, a price-to-earnings-growth ratio of 2.31 and a beta of 0.72. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. Encompass Health Corporation has a one year low of $92.77 and a one year high of $127.99. The stock’s fifty day moving average is $103.40 and its 200-day moving average is $105.28.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.51 by $0.09. The company had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The company’s quarterly revenue was up 9.0% compared to the same quarter last year. During the same period last year, the company earned $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Equities analysts anticipate that Encompass Health Corporation will post 5.96 EPS for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, July 1st. Encompass Health’s payout ratio is presently 12.69%.

About Encompass Health

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.